Gritstone bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Gritstone bio's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 86% to $1,331,000. Profit margin reached -10405%. Total operating expenses were $148,374,000.

Profit Margin

Gritstone bio, Inc. (NASDAQ:GRTS): Profit margin
2016 0 -18.75M
2017 0 -41.37M
2018 1.18M -64.77M -5457.03%
2019 4.36M -90.92M -2083.07%
2020 4.03M -104.61M -2591.31%
2021 46.71M -74.95M -160.44%
2022 9.26M -113.12M -1220.49%
2023 1.33M -138.49M -10404.96%

GRTS Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
1.33M9.26M46.71M4.03M4.36M1.18M00
Cost of revenue
7.59M15.69M14.39M88.64M82.89M01.97M0
Gross profit
-6.26M-6.42M32.31M-84.60M-78.53M1.18M-1.97M0
Operating exp.
Research and development
127.18M111.40M97.49M88.64M82.89M54.96M35.69M13.91M
Selling and marketing
-7.59M0000000
Total operating expenses
148.37M129.69M121.92M110.05M102.30M66.77M41.76M18.98M
Operating income
-154.63M-120.42M-75.20M-106.01M-97.94M-65.58M-41.76M-18.98M
Other income (expenses), net
1.13M741K127K703K3.50M809K386K230K
Income before tax
-138.49M-119.68M-75.08M-105.31M-94.43M-64.77M-41.37M-18.75M
Income tax expense
7.42M-6.56M-127K-703K-3.50M809K00
Net income
-138.49M-113.12M-74.95M-104.61M-90.92M-64.77M-41.37M-18.75M
Earnings per share
Basic EPS
-1.2-1.24-0.95-2.77-2.71-7.26-2.06-0.93
Diluted EPS
-1.2-1.24-0.95-2.77-2.71-7.26-2.06-0.93
Data sourceData sourceData sourceData sourceData sourceData source